Pathological tau aggregates in Alzheimer’s disease (AD) and frontotemporal lobar degeneration-tau (FTLD-tau) adopt distinct conformations differentiated by the AD-tau specific monoclonal antibody (mAb) GT-38 t…

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...